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Summary 
The fate of eukaryotic transcripts is closely linked to their untranslated regions, 
which are determined by where transcription starts and ends on a genomic locus. 
The extent of alternative transcription start and alternative poly-adenylation has 
been revealed by sequencing methods focused on the ends of transcripts, but the 
application of these methods is not yet widely adopted by the community. In this 
review we highlight the importance of defining the untranslated parts of transcripts 
and suggest that computational methods applied to standard high-throughput 
technologies are a useful alternative to the expertise-demanding 5’ and 3’ 
sequencing. We present a number of computational approaches for the discovery 
and quantification of alternative transcription start and poly-adenylation events, 
focusing on technical challenges and arguing for the need to include better 
normalization of the data and more appropriate statistical models of the expected 
variation in the signal. 
  
 
 
Introduction 
The development of high-throughput technologies for transcriptome 
profiling has allowed us unprecedented access to the ensemble of RNA 
transcripts in and out of the cell. Evidence from a growing number of studies 
suggests that both the extent of the RNA repertoire and its complexity have been 
vastly underestimated[1]. Nearly a decade after the introduction of next-
generation sequencing technologies for surveying the transcriptome, it is still 
possible to find novel splicing junctions that were originally overlooked because 
of low expression of the corresponding transcripts[2]. Although  the term “gene” 
[3] has served geneticists well as the unit of heredity, a complete understanding 
of the workings of a cell at the molecular level dictates a shift from a gene-level 
to a transcript (or “isoform”)-level analysis.  
 A transcript-centric approach to quantifying RNA is, however, 
challenging. Alternative splicing of the primary RNA is the most commonly 
studied mechanism of producing gene variants in eukaryotes, but the possibility 
of starting and ending a transcript at different points in the genome through the 
use of alternative transcription start sites (TSS) and alternative poly-adenylation 
and cleavage sites (PCS) adds another layer of complexity to the study of the 
transcriptome. Interestingly, the choice of TSS and PCS are not disconnected[4], 
adding to the intricacies of regulation mediated by the transcript’s untranslated 
regions (UTRs). Although alternative TSS/PCS can result in altered protein-
coding sequences, they often produce isoforms that vary only in their non-coding 
parts (Fig. 1). Such differences in the untranslated regions have been shown to 
affect the stability, localization and translation efficiency of the parent 
transcripts and, more recently, the localization of proteins post-translationally, 
as documented by a number of studies (a selection of examples is presented in 
Box 1 and reviews [5-8] provide a more comprehensive coverage of the subject).  
 Considering the importance of alternative TSS and alternative PCS, it is 
instructive to understand why the vast majority of transcriptomic studies 
employing microarrays or RNA-seq technologies do not attempt to quantify the 
relative expression of isoforms that differ only in their untranslated regions. We 
believe a major issue is lack of comprehensive annotation.  Transcription start 
and end points differ between different tissues [9, 10], developmental stages [11, 
12], and states of health[13, 14](with many more examples presented in the the 
review by Curinha et al.[15]). An accurate analysis of transcriptomic data would 
require a comprehensively annotated version of the reference genome, 
something that is arguably lacking even for the best-studied organisms. Existing 
databases are often focused on humans, but even then agreement between them 
is limited. For example, our comparison of entries in APADB[16] and 
PolyAsite[17] databases  shows that of the 392912 PCS clusters in PolyAsite,  
60186 overlap with at least one of the 71829 clusters in APADB. This means that 
16% of the PCS in the smaller database have no match in the larger one (these 
numbers have been obtained using coordinates rather than gene names which 
would result in a lot fewer hits; overlap is defined very generously as at least one 
nucleotide in common between clusters, with a tolerance of 5 nucleotides on 
either side).  As with many bioinformatics resources, there is an additional issue 
with keeping such databases up to date when new data are published or when 
new reference genome sequences are released. For example, none of the major 
alternative poly-adenylation databases uses the current human genome release 
(hg38), yet this is already the standard for most sequence analysis pipelines. 
Finally, there is an argument that aberrant poly-adenylation might not affect 
only the relative quantities of transcribed isoforms but also the actual sites used. 
In other words, even a complete reference set of poly-adenylation or 
transcription start sites may not be appropriate for samples originating from 
conditions that allow cryptic sites to become sufficiently utilized resulting in 
novel transcription products. 
The lack of comprehensive annotation is a barrier to analyzing 
transcriptomic data but could be overcome by methods that deduce the 
transcript structure directly from the data. Although tempting, this approach 
presents several challenges. Reconstructing the transcriptome from a pool of 
sequenced transcript fragments and quantifying the relative expression of 
isoforms is only straightforward in the simplest scenario of one gene producing a 
single transcript (see relevant reviews by [18-21] for a more thorough coverage 
of the challenges associated with transcriptome reconstruction and isoform 
quantification). In addition to the problems shared with methods that attempt to 
quantify alternative splicing events, methods for probing the ends of transcripts 
are plagued by technical issues linked to biases in next-generation sequencing 
technologies, as discussed below. Sequencing of whole transcripts, as promised 
by the more recent third-generation sequencing technologies (nanopores and 
the single molecule real-time technology (SMRT) platforms), would potentially 
eliminate these issues. Early successes in this direction [22-25] are very 
promising, but there is disagreement in the literature about the error rate 
associated with nanopore sequencing[26-28]. Clearly, these technologies are still 
under active development and many of the technical challenges, such as 
variability of the time intervals used to identify each base, are unresolved [29]. 
The challenges associated with sequencing cDNA with nanopores are also 
hampering direct RNA sequencing with this technology, and in addition, there is 
less evidence in this case that coverage of the transcriptome is to a satisfactory 
degree. One recent non-peer reviewed study[30] suggests promising results but 
also makes it clear that the timeframe required for nanopores to deliver on their 
promises remains uncertain.  
Until sequencing of full transcripts becomes routine, it appears that there 
are two routes to a comprehensive study of the transcripts’ untranslated parts: 
one is to carry out additional experiments that are specifically aimed at probing 
the ends of the transcript; the other is to use computational methods to obtain 
information about alternative TSS and PCS from standard transcriptomic data 
produced by microarrays and RNA-seq. The present review focuses on the 
second option, with a brief description of experimental methods aimed at 
capturing the transcript ends of a gene given in Box 2. The latter methods are 
obviously necessary for benchmarking computational approaches. In summary, 
there are a variety of methods that have been developed for probing both TSS 
and PCS at nucleotide resolution. Many have been used already to provide us 
with great insights on the differential use of transcript ends in different tissues, 
stages of development or disease. However, we believe that the availability of 
these specialized methods to the wider research community remains a challenge. 
The majority of these methods are still only accessible to research groups that 
have the necessary expertise, funds and laboratory set ups to carry out the often 
complex and laborious protocols involved. Until these targeted methods become 
more widely accessible, bioinformatics approaches will constitute a much-
needed alternative solution. In this spirit, we review below computational 
approaches for discovering and quantifying the use of alternative TSS and PCS 
from standard transcriptomic data. 
 
 
 
Computational prediction of alternative TSS and PCS from standard 
transcriptomic data 
 
The availability of genome-wide surveys of transcripts has opened the doors to 
deducing TSS and PCS data for all genes expressed in a given sample using 
computational methods. Although it may be possible to computationally infer 
potential starting and ending points of transcription using genomic data alone 
(see for example studies by [31-45] among many others), methods to do so have 
to rely on sequence signals/motifs or their associated structure and 
thermodynamic properties,  that can, at best, suggest the possibility of a TSS or 
PCS in a genome but cannot ascertain their use at any given time. The topic of 
finding such signals is outside the scope of this review but interested readers are 
directed to the review by Tian and Graber[46]; instead we are focusing here on 
the prediction of TSS and PCS from transcriptomic data.  
Some of the earliest estimates of the use of alternative TSS/PCS have their 
origin in studies that were focused on alternative splicing and, in the absence of 
microarray and next-generation sequencing data, relied on Expressed Sequence 
Tag (EST) contigs and pioneering spliced aligners to identify splicing events. 
Although these studies did not explicitly set out to identify alternative TSS and 
PCS, they did discover large numbers of alternative splicing events in the 
untranslated regions ([47-49]) and often gave information on the predicted 
starts and ends of transcripts based on ESTs. It was the advent of high-
throughput transcriptomic technologies though that fuelled an interest in 
exploring transcripts in detail, including the diversity of untranslated regions. 
Below, we concentrate on bioinformatics methods developed for and applied to 
the more recent transcriptomic data from microarray and RNA-seq experiments. 
   
Quantifying the use of alternative TSS and PCS from microarray data is limited by 
probe design and signal variability 
Microarray chips for surveying the transcriptome predate RNA-seq and in 
theory, if designed appropriately, could be used for accurate prediction of the 
relative use of known TSS and PCS sites in any gene. In microarrays, RNA 
expression is measured through the amount of cDNA that hybridizes to pre-
designed short DNA fragments (probes) immobilized on a chip. Analysis of 
expression at the gene level requires only that some probes cover parts of each 
transcript, but the analysis of untranslated regions and relative quantification of 
alternative 5’ and 3’ ends dictates in addition the requirement for a satisfactory 
coverage of the untranslated parts. It is primarily this requirement that renders 
most microarray chips unusable for discovering alternative transcript ends, or at 
best, limits their use to a small subset of genes. Illumina and Agilent platforms, 
for example, used relatively longer (50- to 60-mer) reads but with their numbers 
of probes per chip ranging between 40,000-50,000, it is obvious that only a small 
subset of genes (if any at all) could be covered adequately for UTR probing. Thus, 
we focus here on chips produced by Affymetrix, which are arguably the most 
widely used in quantification of gene expression. The spread of probes was very 
limited in the first two generations of Affymetrix platforms. GeneChip arrays 
lacked probes in the 5’ UTR, and both they and Exon ST arrays had insufficient 
probes across the 3’UTR to satisfactorily cover alternative-length transcript tails 
(Fig. 2A). As a consequence, there have been only few attempts to quantify 
alternative poly-adenylation site selection using these arrays and, to our 
knowledge, the only study that proposed a method for mapping both ends of a 
transcript from microarray data utilized a high-density tiling array covering the 
whole genomic sequence of Saccharomyces cerevisiae[50].  
All methods developed to find alternative PCS using microarray data rely 
on the fact that microarray chips use “probe sets” rather than individual probes 
to quantify the expression of a gene. Most microarray analysis protocols group 
probes together, if they correspond to sequences derived from the same 
gene/transcript/exon, thus summarizing probe values to the appropriate feature 
level. However, if the individual probes cover both the part of the transcript 
before and after a poly-adenylation site, then it is possible to extract information 
about the relative use of the “short” and “long” tailed transcripts in different 
conditions by calculating the ratio of expression for the probes up- and down-
stream of that site. When applied to 3’UTR events, these methods benefit from 
the fact that UTRs often lack introns (less than ~10% of all annotated introns are 
located outside the protein-coding region[51]) and hence alternative splicing is 
less likely to interfere with the APA signal. Similarly, limiting the search to the 
last exon or employing microarrays with probes heavily biased towards the 
3’UTR further focuses the method on events due to alternative poly-adenylation. 
Although theoretically straightforward and computationally easy to implement, 
comparing levels of individual probes is hindered by the variability in probe 
signal whose origins are technical rather than biological. Our recent experience 
working with several published datasets agrees with earlier studies [52, 53] 
suggesting that the expression levels of individual probes vary widely due to 
biases such as the probe location within the transcript or the similarity of the 
sequence probe  to sequences originating from other non-target genes.  
Despite the non-trivial challenges involved, several methods have been 
published attempting to quantify APA events from microarray data. In a 
pioneering study, Sandberg et al.[54] introduced the probe-level alternative 
transcript analysis (PLATA), a method that uses the individual microarray 
probes to assess differences in expression within a gene, after correcting for 
probe-specific variations and normalizing for gene-level intensities. This 
approach relies on prior knowledge of the PCS (Sandberg et al used EST-
supported poly(A) sites), as does the more recent APAdetect method[55] which 
relies on poly(A) sites from the PolyA_DB database[56]. In contrast, the Rmodel 
method[57], implemented as a package in R, allows identification of novel events 
by comparing individual probe expression ratios in two conditions along the 
gene body and identifying the optimum segmentation point using a modified t-
test. More recently, Li et al[58] replaced the modified t-test in Rmodel with a 
Bayesian analysis following the method of Erdman & Emerson[59] implemented 
in the R package bcp[60]. In their approach, a list of tandem 3’UTRs is first 
constructed from the coordinates of known transcripts with identical 3’ UTR 
start sites but different poly-adenylation sites. Then, the change point is 
identified as the probe with the highest posterior change probability. Finally, the 
fold change between the expression levels of the common and extended regions 
is calculated, filtering out insignificant or unreliably measured changes.  
 Although the methods described above are promising, their performance 
is highly dependent on the microarray design, as well as the quality of the signal 
at the individual probe level. To improve performance, methods usually employ 
some form of filtering to exclude “outlier” probes whose intensities lie on the 
extremes of the distribution defined by the intensities of probes belonging to a 
given set. However, in the case of a small number of probes (<10), a distribution 
would be difficult to define with any confidence, making the identification of 
outliers a practice of debatable value. Additionally, “size” filters can be applied to 
exclude transcripts that do not have enough probes covering the area of interest. 
In practice, however, these filters may be set at unrealistically small cut-offs 
(APAdetect[55], for example, eliminates transcripts with a single distal or 
proximal probe) meaning that as few as two probes may be considered 
acceptable, although it is clear that the statistical value of a comparison of 
intensities between control and condition samples in this case would be 
questionable. 
Most existing microarrays were not designed with complete coverage of 
potential untranslated regions in mind and would not be suitable for discovering 
new TSS/PCS or even quantifying accurately differential use of known sites in 
samples originating from distinct conditions.  The recent introduction of the 
Affymetrix Human Transcriptome Array 2.0 is a promising step in the right 
direction with increased coverage of both the 5’ and 3’ UTR of a substantial part 
of protein-coding isoforms. Although, the platform remains largely unexplored in 
this aspect, it appears that it has the potential to be used for this type of analysis. 
However, it should be kept in mind that even probes in this array cover on 
average ~70% of the 5’ human UTRs but less than 40% of the 3’ and (Fig. 2B), 
limiting its applicability to a subset of annotated genes.  
 
RNA-seq can reveal alternative TSS and PCS events but accounting for technical 
biases is not trivial  
RNA-seq technology transformed transcriptome profiling providing 
information on the full length of both known and novel transcripts, including the 
much under-studied untranslated regions. In RNA-seq data, microarray-style 
predefined probes are replaced by “reads”, fragmented pieces of RNA ranging in 
length from 25 to few hundreds of nucleotides depending on the protocol and 
platform. These reads potentially cover the entire length of each RNA in a 
sequenced sample, making it possible, in theory at least, for any region of an RNA 
transcript that is sufficiently expressed to be detected by the method. In reality, 
most RNA-seq protocols suffer from relatively poor coverage of the 5′ ends of 
RNAs, and poor representation or biased over-representation of the 3’ end, 
depending on the technology used[61]. For example, fragmentation bias can lead 
to either strong depletion of reads at the 5’end (when cDNA is fragmented) or 
milder depletion of reads at both ends (when RNA is fragmented)[61]. Given the 
difficulty of obtaining good quality data for the 5’ end, it is not surprising that 
hardly any methods have been developed specifically for identification of TSS 
from RNA-seq data. RNA degradation, a common problem during the storage and 
preparation of samples, plagues RNA-seq libraries and as a result, disappointing 
levels of RNA integrity are not uncommon among transcripts in publicly 
available RNA-seq datasets. In RNA-seq libraries prepared using the polyA+ 
selection method, the 3’ ends of transcripts are protected from degradation, 
leading to a higher number of reads at the end of the transcript, and a 
corresponding density peak close to the end of degraded transcripts. In libraries 
derived from ribosome depletion, the 3’ end is not protected and read coverage 
is generally lower at both 5’ and 3’ ends[62]. Despite these challenges, the 
reasonable coverage of 3’ ends by RNA-seq reads in combination with the 
promise of potential discovery of novel sites, has prompted the development of a 
variety of methods for the analysis of alternative PCS using next-generation 
sequencing data. It should be obvious here that for all computational methods 
that rely on changes in the expression signal, rather than sequence or structure 
motifs, the two ends of the transcript are indistinguishable; a method defined for 
one end would generally be applicable to both ends, with only minor 
modifications. 
Current computational tools fall into either of two major categories: 
Those that rely on existing annotations of TSS/PCS and aim only to quantify the 
different-length isoforms and those able to predict the position of the transcript 
ends from the distribution of RNA-seq reads. Tools from the first category are 
clearly more limited in their applicability as databases are currently focused on a 
limited number of tissues and organisms, and as highlighted earlier, it is 
debatable that any single one used in isolation comprehensively covers all 
potential alternative events (Table 1 summarises web-accessible databases with 
information on alternative PCS and TSS).  
Despite the challenges of using existing annotation to support the 
prediction of alternative PCS or quantify their use, a number of methods follow 
this approach. The mixture-of-isoforms model, or MISO[63], was developed to 
estimate the expression of alternatively spliced exons or isoforms but can be 
used also to estimate expression of isoforms resulting from APA events. For 
MISO to infer the abundance of isoforms using Bayes’ rule (the ‘percent spliced 
in’ or PSI value[64]), it requires knowledge of which isoforms a read is 
compatible with and hence knowledge of the splice junctions (or in the case of 
poly-adenylation, the PCS sites) in order to build the isoform compatibility 
matrix. The Bioconductor package roar (=ratio of a ratio) (Grassi 2013) requires 
similarly an annotation file with the coordinates of the canonical and alternative 
poly-adenylation site for each gene. Although roar allows only two sites per gene, 
the package can handle multiple pairwise comparisons between the canonical 
end and different alternative PCS. This is used to assign each read to either the 
portion of the gene that belongs to the long isoform only (‘POST’), or the portion 
that is common to the short and long isoforms (‘PRE’). The ratio of short to long 
isoform expression is then estimated, taking into account the length of each 
isoform. The statistical significance of the difference between PRE and POST 
counts in two samples (e.g. treatment versus control) is assessed using a Fisher 
test. This approach, like others that attempt to estimate the actual isoform 
expression, assumes that reads are uniformly distributed along the length of the 
transcript, an assumption that is unlikely to be true in any real RNA-seq dataset. 
 
Methods that rely on transcript reconstruction are computationally 
expensive and must solve the problem of assigning reads to overlapping 
isoforms  
The second category of methods do not rely on an existing annotation of 
PCS but instead try to deduce the use of alternative poly-adenylation sites 
directly from the data. Some of these tools rely on transcript reconstruction 
methods, such as Cufflinks[65], to provide them with a list of transcripts that are 
consistent with the available reads in a sample. Thus, they delegate the difficult 
problem of putting transcripts together to external software, whereas they deal 
with the relatively easier question of identifying 3’UTR lengths that do not match 
the genome annotation, and then comparing quantitatively the use of alternative 
PCS across samples. The 3’UTR Sequence Seeker (3USS) server[66] is an example 
of a method that relies on the output from genome-guided transcript 
reconstruction carried out by Cufflinks. The 3’UTR lengths of transcripts sharing 
a common chain of introns are compared to the corresponding annotated 
transcripts to discover alternative PCS.  This way, both previously known and 
novel alternative PCS can be identified in the data. Although the 3USS server can 
highlight cases where an alternative PCS is exclusively used in one sample, it 
cannot quantify differential use of alternative PCS in different samples. Given 
that in the majority of cases the selection of a PCS is not a binary event (i.e. not 
simply on or off), methods attempting to quantify the relative use of two or more 
PCS across samples are potentially more useful. An additional issue with tools 
that employ the output of transcript reconstruction methods is that they cannot 
distinguish between short and long 3’UTR isoforms, if these isoforms contain the 
same exons. In these cases, the short isoform is embedded in the long and reads 
originating from the part of the transcript common to both isoforms cannot be 
assigned to short or long in a straightforward manner. Hence, methods that rely 
on reconstruction of transcripts based on their exon composition will almost 
certainly fail to identify alternative PCS or correctly deduce their relative use 
across samples.  
In order to overcome the shortcomings of incomplete genome 
annotations, some tools employ de novo transcriptome reconstruction prior to 
searching for alternative 3’UTRs. Both KLEAT[67] and PASA[68] implement 
pipelines that rely on such de novo reconstruction, a process notorious for its 
demands on computational power (it should be noted that PASA can be used in 
the context of APA analysis but was developed with the aim of automatically 
modeling gene structures using spliced alignments and hence, its scope extends 
far beyond APA discovery and quantification). However, even assuming that de 
novo reconstructions will become more routinely accessible with time, their 
inability to reconstruct lowly expressed transcripts fully and correctly is likely to 
remain an issue. Perhaps more problematic than either accuracy or complexity 
in this case is the fact that when it comes to deciphering poly-adenylation sites, 
these tools seem to rely heavily, if not entirely, on the presence of poly(A)-
capped reads in the data, i.e. reads that are produced from the end of the 
transcript and have thus stretches of untemplated As that cannot be mapped to 
the genome. The idea of using such reads has been around since the early days of 
RNA-seq[69] and, in combination with the use of a library enriched in poly(A)-
spanning reads, it allowed the discovery of  a great number of unannotated poly-
adenylation events in Drosophila melanogaster[70]. More recently, it has been 
suggested that mapping of poly(A)-spanning reads should become standard 
practice which led to the incorporation of this method into the Context Map 2 
RNA-seq mapping pipeline[71]. Although these studies are evidence of the 
increasing popularity of this approach, the issue with relying on poly(A)-
containing reads is that they are actually rather scarce in standard RNA-seq 
datasets (where libraries are not specifically enriched in poly(A)-carrying reads), 
their number being largely dictated by read coverage of the 3’ end. Our analysis 
of the relatively recent dataset by Bayerlová et al.[72] showed that only ~0.1% of 
reads have at least 6 As at the end, a percentage consistent with that obtained for 
other datasets we have examined in the past. A more thorough analysis by Kim et 
al.[73] found just over 10% of 130 million unmapped reads had at least two 
untemplated As in their 3’end, and following removal of these As only ~0.1% of 
the original reads could be uniquely mapped to the genome. The reads that 
mapped successfully provided poly-adenylation cleavage site information for 
just ~2000 protein-coding genes, suggesting that reads with untemplated As are 
of limited use in the analysis of APA events. In our opinion, the fact that fairly 
complex de novo reconstruction protocols are actually limited by the relatively 
trivial step of identifying poly(A) stretches at the end of reads makes them less 
attractive for analyzing the 3’ end of transcripts. In addition, this approach is 
clearly not suitable for the 5’ end, where no equivalent sequence signals the 
beginning of the transcript. 
 
Detection of read density fluctuations in RNA-seq data allows the discovery 
of novel events but is prone to high false positive rates 
A final group of algorithms bases PCS recognition on read density 
fluctuations. The number of mapped RNA-seq reads at each position along the 
UTR is considered and the algorithms generally search for a sudden fluctuation 
in the number of reads, indicative of a transcript start or termination event that 
is embedded in the genomic sequence within a longer transcript (Fig. 3). A 
method that delineates both the 5’ and 3’ ends of transcripts using read density 
fluctuation was included in the very first paper describing RNA-seq[74] although 
its description was limited to the detection of a “sharp” reduction in the level of 
transcription with no further details. Since then, several studies have adopted 
this approach employing a variety of computational algorithms. It is important to 
highlight that all methods relying on read density fluctuations are prone to 
inaccurate predictions caused by variations whose origin is not biological (see, 
for example, [75, 76] and, at least in principle, need to normalize or smooth the 
data to avoid such technical biases. Kim et al’s GETUTR method[73] applies a 
choice of three algorithms to smooth the RNA-seq signal prior to finding the local 
maximum-gradients in the new monotonically decreasing signal landscape that 
are thought to coincide with the poly-adenylation cleavage sites. Due to the low 
computational complexity of the algorithm, the method is applicable to 
processing very large datasets but the software seems to be limited to finding the 
cleavage sites, without attempting a quantification of relative expression of the 
corresponding isoforms. Lu and Bushell’s PHMM method[77] employs Hidden 
Markov Models (HMMs) to treat alternative poly-adenylation events as 
transitions between two distinct (and hidden) states, a “high expression” state 
corresponding to the part of the UTR that is contained in both short and long 
isoforms and a “low expression” state corresponding to part covered only by the 
longer isoform. Transcripts for which a two-state model has a better fit than a 
one-state model are selected and the method looks for transitions in the Markov 
chain from high to low expression states in the sequences. A sliding window of 
100 to 800 bases (depending on the length of the 3’ UTR) is used to smooth the 
data and reads are counted against these overlapping windows. Read counts at 
any given window are dependent on the state generating them and are modeled 
using a Poisson distribution. The Poisson assumption is problematic with data 
that is very likely to be over-dispersed (as is the case with RNA-seq data), and 
this may be one of the reasons why the estimated specificity of the method is a 
lot lower than its sensitivity. Moreover, issues of heterogeneity of the read 
density in RNA-seq may be contributing to the high number of false positives, 
and there are additional issues that have not been addressed, such as the 
problem of taking into account multiple samples per condition. ChangePoint[78] 
is another method that attempts to discover the points that mark the transition 
in read density expected at an internal poly-adenylation site. It uses a 
generalized likelihood ratio statistic to evaluate the significance of these 
transitions and, additionally, it applies a directional multiple testing procedure 
for controlling the mixed directional False Discovery Rate (FDR). In essence, the 
latter ensures that only the most significant events are reported, because in a 
multiple testing scenario such as the one here (where thousands of genes are 
routinely considered), it is these large magnitude events that are more likely to 
be relevant to the conditions examined. A drawback of ChangePoint is that it 
cannot analyse more than one sample per condition. The Isoform Structural 
Change Model (IsoSCM)[79] approach is built on the same principle of looking 
for change-points in the read density, but it is based on a Bayesian model and 
allows for multiple change-points to be discovered. Importantly, the discovery of 
the sites by IsoSCM is entirely done ab initio and does not rely on the presence of 
a reference annotation, which limits the applicability of a method to model, well-
studied organisms. However, the current implementation of IsoSCM can also 
only be applied to pairwise comparisons of samples, making it difficult to analyse 
data with biological replicates, unless samples from the same condition are 
pooled together. DaPars [80], in contrast allows the analysis of an arbitrarily 
large number of samples. It works by first predicting the proximal PCS by 
minimizing the difference between observed and estimated read density, based 
on a two-site model.  Although the original publication by Xia et al. suggests both 
a way to infer the distal PCS from RNA-seq data and a generalization to solving 
the problem when multiple sites are present, the publicly available DaPars 
software relies on annotated distal PCS as input and can only work with a two-
site model. Following identification of a proximal site, DaPars quantifies the 
relative use of the two sites between two conditions using the Percentage of 
Distal PolyA site Usage Index, or PDUI, value. PDUI is defined for each sample as 
the ratio of the estimated expression of the long transcript over the sum of the 
estimated expression values for the long and short transcripts. Hence, the 
greater the PDUI value, the more the distal poly-adenylation site is used. Mean 
PDUI values can be calculated across any number of samples and the difference 
of these values between two conditions is indicative of a differential APA event. 
DaPars assigns statistical significance to these differences by carrying out a 
Fisher exact test on estimated expression values for long and short transcripts 
between two conditions and corrects for multiple testing using the Benjamini-
Hochberg approach. Finally, DaPars suggests filtering further the results for size 
of effect by highlighting events with higher ΔPDUI values (>=0.2) and fold 
change in PDUI of at least 1.5 (both are user-defined parameters and can be set 
to different values). Although DaPars is possibly the most widely applicable of all 
methods detecting APA events, given that it can be used with multiple samples 
and does not require prior knowledge of the proximal PCS, it has its own 
limitations.  From a practical point of view, we have found that DaPars requires 
very good coverage at the 3’ end to discover APA events, and will often only 
consider fewer than 10% of all genes expressed in a sample, rejecting the rest 
due to lack of adequate coverage. Another limitation (not inherent in the DaPars 
algorithm but stemming from the software implementation of it), common to all 
methods that search the read data for cleavage events prior to annotated ends of 
transcripts, is that events representing lengthening of the 3’UTR (compared with 
the reference) are missed. For a method to discover these events, it needs to look 
beyond the annotated ends of transcripts. Moreover, in order to estimate the 
long and short transcript expression, DaPars implements a basic normalisation 
method for RNA-seq data, adjusting the counts for a region in a given sample by a 
weight factor corresponding to the sequencing depth difference between that 
sample and the mean of all other samples. This effective normalization by library 
size is known to cause biases in the outcome, if there are large differences in the 
expressed gene populations between samples. Additional biases resulting from 
covariates (e.g. gender, age, sequencing centre etc) affecting gene expression in 
each sample are also not taken into account, but these can influence the results 
where heterogeneous samples per condition are analysed. The statistical test 
used by DaPars may also be problematic, although the extent to which this 
affects the predictions of significant events is difficult to estimate. DaPars 
essentially compares normalized transcript expression values using a Fisher 
exact test. In other words, the values in the contingency table are no longer raw 
counts and hence the validity of how the test is applied may be questioned. 
Independence tests are common in many similar scenaria and have been used 
since the early days of analyses of differential PCS usage events [64]. However, 
applications using single test methods like chi-square or Fisher tests do not take 
into account replicates of a biological condition. Instead, they find ways of 
averaging values from the replicates in order to construct a contingency table 
with just one value per condition. The recently proposed non-parametric RAX2 
method (ranking analysis of chi-squares)[81] attempts to overcome this problem 
by extending the chi-square test to the case of replicated count data from high-
throughput transcriptomic experiments. An additional problem with the 
traditional chi-square or Fisher exact tests emerges in the case of multiple 
PCS/TSS; these tests ignore the order of columns in the contingency table and 
hence, there is an argument for the use of alternatives that would be more 
sensitive when information from multiple sites is available. Regression models of 
the expected read counts may be a more suitable alternative, especially if they 
allow the error distribution to account for overdispersion. In addition, such 
models can naturally accommodate the presence of covariates, as implemented 
in the Generalised Linear Models included in the differential expression software 
solutions offered by DESeq2[82] and EdgeR[83].  
More sophisticated methods for detecting and quantifying alternative 
poly-adenylation (as well as alternative TSS selection) are likely to be inspired 
by methods concentrating on the identification of alternative splicing events 
from RNA-seq data. The recently proposed change-point model that discovers 
splicing events in the 5’ and 3’ end of transcripts[84] is a promising step towards 
a more statistically robust method at finding read-density fluctuations in 
transcriptomic data. It uses negative binomial distributions with different 
parameters to describe read coverage in the common and extended regions of 
two isoforms separated by a splicing event. Additionally, it utilises annotation 
information or splice junction reads to assign different weights to each position, 
thus affecting the prior probability of each being a change-point. It is easy to see 
how a poly-adenylation sequence signal could be used in a similar manner when 
searching for isoforms that share the same splicing events but differ in their UTR 
lengths. Finally, the method employs an empirical Bayes estimator that allows 
pooling information across genes and results in powerful and accurate 
predictions of the change-points in the data.  
As annotation of TSS and PCS becomes more complete and computational 
methods for the detection of alternative UTRs from high-throughput 
transcriptomic data mature, it is likely that initiatives will be set up to facilitate 
the study of the 5’ and 3’ UTRs using a combination of databases and software. In 
this spirit, the recently established expressRNA site 
(http://www.expressrna.org/) offers an integration of computational tools for 
the analysis of APA events. This and other future initiatives promise a more 
detailed, and ultimately more accurate, picture of the transcriptome.  
 
 
 
Conclusions and prospects 
The undisputed functional role of untranslated regions in eukaryotic 
regulation of gene expression dictates an emphasis on the development of 
isoform-centric approaches to data analysis. Until sequencing methods directed 
at both untranslated regions become widely accessible, it is important to focus 
on the easier to implement and more cost-effective computational approaches 
that can be applied to data from standard transcriptomic experiments. Methods 
aimed at identifying the TSS and PCS from the expression signals are of 
particular interest, as it remains debatable whether current annotations can be 
used reliably in the case of biological samples originating from conditions that 
have not been studied before. Importantly, although many existing methods 
were developed to study only one end of the transcripts, many have the potential 
to be applied to both transcript ends, allowing for a complete analysis of the 
transcriptome, given enough coverage. 
The accurate identification of alternative TSS and PCS and the 
quantification of their differential use across samples by computational methods 
are undoubtedly challenging. One of the major hurdles remains the bias in read 
densities that is attributable to technical rather than biological origin. In this 
case, methods can take advantage of existing normalization procedures 
borrowed from recently developed robust differential expression software. The 
ability to process together multiple samples in order to contrast the use of 
alternative ends in different conditions is also a significant challenge. The use of 
multiple samples from heterogeneous origins adds the complication of dealing 
with confounding variables such as the site or type of sequencing, or 
characteristics of the sample’s provenance (e.g. age, gender or ethnicity that 
often confound studies of human biological samples). Statistical methods that 
allow the inclusion of such covariates would be required for accurate modeling 
of the data. Finally, future developments should aim to include robust statistical 
methods that are appropriate for dealing with over-dispersed count data. The 
conspicuous lack of such methods may be at the root of low specificity in many 
cases where significance of variations in the use of sites across conditions is 
evaluated. We believe the field is ripe for further exploration and method 
development. 
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Box 1. 
Selected studies highlighting the role of alternative transcription start and 
alternative poly-adenylation sites in gene expression 
 
Alternative promoters regulate the choice of poly-adenylation sites in the X-linked 
MID1 gene [4] 
The MID1 3’ UTR comprises four polyadenylation sites and the selection of these 
sites is linked to promoter usage, as confirmed by RT-PCR experiments utilizing 
primers covering different exons in the 5’ UTR. This suggests that factors 
interacting with both ends of the gene may be simultaneously regulating the two 
UTR lengths. 
 
Cancer cells evade miRNA repression by shortening the 3’ UTR of transcripts [85] 
In some cancer cell lines shortening of the 3’ UTR leads to isoforms that are more 
highly expressed, primarily through the evasion of miRNA-mediated repression. 
 
The efficiency of translation depends on the length of the 5’ UTR [86] 
Short and long isoforms of 9 yeast genes show different translation efficiencies 
depending on the 5’ UTR length, with two of the genes tested showing > 100-fold 
difference in translation activity. 
 
3’ UTRs control the fate of a gene product post-translationally [87] 
In human cell lines, the 3’ UTR of the CD47 transcript recruits a protein complex 
and transports it to the site of translation, where it subsequently interacts with 
the newly synthesized protein to allow its translocation to the plasma 
membrane. 
 
Selective recruitment of transcript variants to polysomes based on their 5’ UTRs 
allows rapid cell response with no changes to the transcriptional programme [88] 
A study of the transcriptome and translatome (transcripts associated with 
polysomes) in both tumour and normal breast cell lines points to cell-specific 
heterogeneity in transcript leaders (5’ UTRs) as well as differential recruitment 
of transcript variants by ribosomes in disease states.  
 
Stress induces alternative poly-adenylation and regulates gene expression in 
mammalian cells [89] 
Poly(A) sites were mapped using the 3’T-fill method in control and stress-
provoked HEKT293 cells. 401 genes were shown to exhibit stress-induced 
alternative poly-adenylation and the majority of these events did not affect 
directly mRNA abundance but instead were linked to changes in the mRNA 
configuration. 
 
  
 
 
Box 2.  
An overview of experimental methods for probing alternative TSS and PCS 
A relatively limited number of methods have been developed to capture 
the 5' end of transcripts at nucleotide resolution. Initial efforts based on a 5’ 
version of Serial Analysis of Gene Expression (SAGE)[Hashimoto et al. 2004)] or 
the capturing of the 7-methylguanosine cap (Cap Analysis of Gene Expression or 
CAGE [Shiraki et al. 2003; Carninci et al. 2005; Kodzius et al. 2006) have been 
superseded by versions that rely on next-generation sequencing (DeepCAGE[90]  
and HeliScopeCAGE[91].  HeliScopeCAGE is of particular interest as it is built on 
single molecule sequencing technology, avoiding the clonal amplification step 
that potentially leads to quantification bias, as well as several other error-prone 
steps such as second strand synthesis, ligation and digestion. Nano-cap analysis 
of gene expression (nanoCAGE)[92] uses the template switching method (Zhu et 
al. 2001) for reverse transcription, reducing the amount of starting RNA material 
needed but, importantly, not at the cost of coverage. However, template 
switching can introduce artifacts (cDNAs that are artificially shorter than the 
corresponding RNAs) owing to a process known as strand invasion[93]. 
Moreover, as with all CAGE-based methods, nanoCAGE may produce tags 
covering the whole transcript (a phenomenon known as “exon painting”[94]), 
rendering the calling of TSS challenging. Hence, caution is advised in the 
interpretation of intra-genic clusters of CAGE reads as alternative TSS. 
Like its 5’ equivalent, the 3’ specific SAGE-based method[95] has been 
superseded by a variety of RNA-seq derivatives focused on the 3’ end of 
transcripts. Several protocols have been developed but there is considerable 
overlap between many of these approaches. For example, the PolyA-seq [96] and 
PAS-Seq [12] methods vary only in minor technical details such as the type of 
primer used. The majority of protocols capture the ends of transcripts by relying 
on oligo(dT)-primed reverse transcription–PCR (RT–PCR) for library 
construction. This approach has the drawback that primers hybridize to 
intergenic stretches of adenosines, resulting in internal priming and interfering 
with the prediction of the PCS. A variety of methods have been created to deal 
with this problem. The earlier Sequencing APA Sites (SAPAS) method filters 
reads resulting from internal priming during the bioinformatics analysis 
pipeline[14]. Similarly, Wang et al.[97] have suggested a bioinformatics solution 
to filtering out internal priming events; the method takes advantage of the 
distinct nucleotide composition patterns found around poly-adenylation sites to 
computationally identify authentic 3’ end cleavage events. The 3’READS method 
(Hoque et al. 2012) minimises the internal priming problem by elongating 
oligo(T) primers to 45 bp, whereas “hot priming” has been used by Muller et 
al.[16] during the hybridization step of Massive Analysis of cDNA Ends 
(MACE)[98] to avoid the same problem. In 3P-Seq[99] a biotinylated double-
stranded oligo (with overhanging stretch of Ts) is ligated to the end of the 
poly(A) tail, avoiding the need for oligo(dT) priming. Another issue that must be 
addressed by protocols that sequence in the sense direction, i.e. that start the 
sequencing within the transcript and proceed towards the poly(A) tail (e.g. A-
seq[100]), is fragment selection: fragments must be long enough to allow the 
production of mappable reads to the genome, whilst at the same time allowing 
the polya-denylation site to be reached. When the protocol supports reading 
through the poly(A) site, the resulting reads suffer from low quality[101]. The 3’ 
T-fill method[101] avoids reading through the poly(A) tail by filling in the stretch 
of As with base-pairing unlabeled dTTPs, forcing sequencing to start directly 
after the tail and into the 3’UTR region. The PAT-Seq method[102] opts for the 
opposite approach, deliberately including the poly(A) tail in the sequencing, but 
avoiding the problems associated with sequencing homopolymers by starting 
the sequencing on the 5’ end of fragments. The inclusion of the poly(A) stretch 
allows studies that correlate the adenylation state to gene expression, measuring 
3’UTR dynamics on a genome-wide scale. The above protocols are powerful in 
providing the precise locations of PCS, but complex library preparation steps 
make them error-prone and introduce technical biases; adaptor ligation, for 
example, can yield poor quantification in deep sequencing because of significant 
bias introduced by RNA ligase[103]. The recently proposed Poly(A)-Clickseq 
(PAC-seq) method[104] avoids sample purification and poly(A) enrichment, as 
well as the RNA fragmentation and adaptor ligation steps by using azido-
nucleotides to terminate cDNA synthesis just upstream of the 3’UTR-poly(A) 
junction, followed by click-chemistry to allow the ligation of special Illumina 
adaptors prior to PCR amplification. Another promising alternative approach is 
Direct RNA Sequencing (DRS) [105]. Similarly to HeliScope-CAGE, DRS has the 
major advantage of avoiding the reverse transcription–PCR step during library 
construction by sequencing directly captured poly-adenylated RNAs on 
oligo(dT)-coated slides. The DRS method requires very small amounts of RNA 
and has been shown to quantitatively reflect the amount of transcript isoform 
present in the RNA sample [105]. This promising technology is yet to be widely 
implemented, possibly due to higher error rates compared with other methods.  
 A limitation of methods that focus on either the 5’ or the 3’ end is that 
they essentially require three different experiments to probe the two UTRs and 
coding region of the mRNA. Consequently, experimental methods that combine 
3’ and 5’ sequencing are obviously advantageous and potentially time and cost-
efficient. Tag-based transcript-isoform sequencing (TIF-Seq)[106] and RNA-
PET[107] offer such solutions using paired-end sequencing. Both methods 
combine approaches developed for directed 3’ and 5’ sequencing. RNA-PET 
combines protocols from 3’-SAGE and 5’-CAGE to capture both ends of 
transcripts, whereas TIF-Seq employs nanoCage for 5’ and oligo(T)- primer for 3’ 
sequencing. Both methods are limited in their coverage. More specifically, RNA-
PET identifies a much smaller number of isoforms compared with the directed 
sequencing approaches, whereas TIF-Seq results are affected by strong bias 
towards short RNA molecules[106]. 
 
 
  
Table 1. 
List of databases with information on alternative transcription start sites (TSS) and alternative poly-adenylation and cleavage sites (PCS) 
Database 
name 
Alternative 
PCS or TSS 
Organism Technology Comments Web address Reference 
PolyA_DB (2) PCS Human; Mouse; Rat; 
Chicken; Zebrafish 
cDNA/EST and TRACE  http://exon.umdnj.edu/polya_db/ Lee et al. 2007[108] 
AURA 2 PCS Human; Rhesus; Dog 
Mouse; Rat 
PolyA-seq This is a “meta” database. Alternative UTR 
information is from [109] 
http://aura.science.unitn.it/ Dassi et al. 2014[110] 
PlantAPA PCS Plants EST, PAT-seq, Poly(A)-tag Only plant species are included in this 
database. 
http://bmi.xmu.edu.cn/plantapa/ Wu et al. 2016[111] 
PolyASite PCS Human; Mouse 2P-seq, 3’Seq, 3’READS,  
3P-Seq, A-seq, A-seq2, DRS, 
PAS-Seq, PolyA-seq, SAPAS 
 http://polyasite.unibas.ch Gruber et al. 2016[17] 
PACdb   EST Uses an older version of the human 
genome (hg18) 
http://harlequin.jax.org/pacdb/ Brockman et al. 
2005[112] 
APADB PCS Human; Mouse; 
Chicken 
Massive Analysis of cDNA 
Ends (MACE) 
 http://tools.genxpro.net/apadb/ Müller et al. 2014[16] 
APASdb  Human; Mouse; 
Zebrafish 
SAPAS  http://genome.bucm.edu.cn/utr/ You et al. 2015[113] 
DBTSS TSS Human 
 
TSS-seq Uses an older version of the human 
genome (hg18) 
http://dbtss.hgc.jp Suzuki et al. 2015[114] 
Figure Captions 
Figure 1.  
Schematic representation of alternative transcription start site and 
alternative poly-adenylation events of interest to this review. 
The presence of two alternative TSS and two alternative PCS creates four 
possible transcripts from the same genomic locus (top). TSS1 creates transcripts 
with longer 5’ UTRs compared with TSS2, whereas PCS1 creates transcripts with 
shorter 3’UTRs compared with PCS2. The use of alternative TSS/PCS regulates 
the inclusion or exclusion of functional elements such as upstream open reading 
frames (uORFs) in the 5’ UTR or miRNA and protein-binding sites in the 3’ UTR.  
The coding regions (light grey boxes and grey lines) may or may not be different 
between the transcripts, depending on the action of alternative splicing. In this 
review we are only concerned with differences in the untranslated regions (blue 
and yellow). 
 
Figure 2. 
The distribution of microarray probes along the length of the transcript 
limits their usability for genome-wide studies of alternative TSS and PCS. 
A & B: 
The mapped position of microarray probes for three generations of Affymetrix 
chips are shown as coloured rectangles along the 5’ (A) and 3’ UTR (B) of two 
transcripts (brown, pink and blue for Human Genome 133 Plus, Human Exon 1.0 
ST and Human Transcriptome Array 2.0 respectively). Annotated TSS and PCS 
sites are shown as brown vertical lines along the body of the UTR. Even in the 
simplest case of a single TSS site (A), it is obvious that only the recently 
developed Human Transcriptome Array contains enough probes to give 
satisfactory coverage of both alternative 5’ UTRs. In the more complex case of 
multiple known sites shown in (B), even the extended coverage provided by HTA 
2.0 is not sufficient for unambiguous discovery and quantification of alternative 
poly-adenylation events for this transcript. 
C & D: 
The Human Transcriptome Array 2.0 platform displays good coverage of the 5’ 
UTR (C; left) with a median number of 20 probes per transcript. Splitting the 5’ 
UTR into quartiles along its length and calculating the coverage of each from the 
HTA 2.0 probes indicates a reasonable distribution of probes along the length of 
the UTR (C; right). The coverage of the 3’UTR by the same microarray chip is 
worse (D; left), despite a higher median number of probes (23). This discrepancy 
is due to the generally longer lengths of the 3’ as compared with the 5’ UTRs. 
Encouragingly, the distribution of probes along the length of the 3’UTR is also 
good with only a small bias towards the first quartile (D; right). 
 
  
Figure 3. 
Discovering alternative poly-adenylation events from read density 
fluctuations in RNA-seq data. 
Reads from an RNA-seq experiment[72] are mapped to the reference genome 
and the density of the reads is displayed as a Sashimi plot, depicting coverage 
along the gene body  (only the 3’ end of the transcripts are shown for genes 
EIF2S3 and XRN2). Black vertical lines mark the annotated PCS sites from the 
PolyASite database[17]. The two vertical red lines represent the sites predicted 
by the program DaPars as alternative poly-adenylation sites, based on a drop in 
read densities along the 3’ UTR. (DaPars is using a number of samples to identify 
the sites, not just the one shown here). The DaPars prediction agrees well with 
one of the annotated PCS sites in the EIF2S3 gene (A) but lies far from the 
annotated proximal PCS site in the XRN2 gene (B). However, the drop in read 
density around the DaPars predicted site suggests the possibility that the 
prediction is correct. Clearly, the presence of multiple peaks in density in (A) 
would be challenging for any software that predicts APA events using density 
fluctuations in the RNA-seq signal. 
